ATE51342T1 - Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe. - Google Patents
Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe.Info
- Publication number
- ATE51342T1 ATE51342T1 AT86301949T AT86301949T ATE51342T1 AT E51342 T1 ATE51342 T1 AT E51342T1 AT 86301949 T AT86301949 T AT 86301949T AT 86301949 T AT86301949 T AT 86301949T AT E51342 T1 ATE51342 T1 AT E51342T1
- Authority
- AT
- Austria
- Prior art keywords
- topical
- systematic
- agents
- agent
- controlling
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/713,068 US4692462A (en) | 1985-03-18 | 1985-03-18 | Compositions and method of controlling transdermal penetration of topical and systemic agents |
EP86301949A EP0195643B1 (de) | 1985-03-18 | 1986-03-17 | Mittel und Vorrichtung zur Steuerung der transdermalen Penetration topischer und systematischer Wirkstoffe |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE51342T1 true ATE51342T1 (de) | 1990-04-15 |
Family
ID=24864618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT86301949T ATE51342T1 (de) | 1985-03-18 | 1986-03-17 | Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4692462A (de) |
EP (1) | EP0195643B1 (de) |
JP (1) | JPS61215321A (de) |
AT (1) | ATE51342T1 (de) |
DE (1) | DE3669828D1 (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5135477A (en) * | 1984-10-29 | 1992-08-04 | Medtronic, Inc. | Iontophoretic drug delivery |
US4839345A (en) * | 1985-03-09 | 1989-06-13 | Nippon Oil And Fats Co., Ltd. | Hydrated adhesive gel and method for preparing the same |
US4710191A (en) * | 1985-12-16 | 1987-12-01 | Jonergin, Inc. | Therapeutic device for the administration of medicaments |
US4915685A (en) * | 1986-03-19 | 1990-04-10 | Petelenz Tomasz J | Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange |
US4906475A (en) | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
DE3843237A1 (de) * | 1988-12-22 | 1990-07-05 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit einem antiadipositum als aktivem bestandteil |
JP3286315B2 (ja) * | 1990-06-20 | 2002-05-27 | アドバンスト ポリマー システムズ,インコーポレイティド | 可溶性活性物質の調節された放出のための組成物及び方法 |
SE9003903D0 (sv) * | 1990-12-07 | 1990-12-07 | Astra Ab | New pharmaceutical formulations |
US5402777A (en) * | 1991-06-28 | 1995-04-04 | Alza Corporation | Methods and devices for facilitated non-invasive oxygen monitoring |
US5267563A (en) * | 1991-06-28 | 1993-12-07 | Nellcor Incorporated | Oximeter sensor with perfusion enhancing |
JPH07500113A (ja) * | 1991-10-16 | 1995-01-05 | リチャードソン、ビックス、インコーポレーテッド | 薬物の改善された局所送達用の高皮膚浸透系 |
US5260066A (en) * | 1992-01-16 | 1993-11-09 | Srchem Incorporated | Cryogel bandage containing therapeutic agent |
US5296228A (en) * | 1992-03-13 | 1994-03-22 | Allergan, Inc. | Compositions for controlled delivery of pharmaceutical compounds |
CA2078960A1 (en) * | 1992-04-21 | 1993-10-22 | John Wick | Hydrogel applicator and methods of making same |
WO1994008572A1 (en) * | 1992-10-15 | 1994-04-28 | Alza Corporation | Delayed onset transdermal delivery device |
KR0121127B1 (ko) * | 1994-05-09 | 1997-11-13 | 강박광 | 이온성 고분자 네트웍을 갖는 피부약물전달체계 |
USRE38827E1 (en) | 1994-07-27 | 2005-10-11 | 3M Innovative Properties Company | Adhesive sealant composition |
US5583114A (en) * | 1994-07-27 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
US5846525A (en) * | 1995-12-19 | 1998-12-08 | Trega Biosciences, Inc. | Protected biopolymers for oral administration and methods of using same |
WO1997027844A1 (en) * | 1996-01-30 | 1997-08-07 | Novagent Oy | Composition for transdermal delivery of drugs |
US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
US6797276B1 (en) | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
US7629384B2 (en) * | 1997-09-17 | 2009-12-08 | Strategic Science & Technologies, Llc | Topical delivery of L-arginine to cause beneficial effects |
KR100315160B1 (ko) * | 1998-01-09 | 2002-05-13 | 김충섭 | 피부수렴제가첨가된경피투여용약제조성물 |
FI107372B (fi) * | 1999-04-29 | 2001-07-31 | Novagent Oy | Laite vaikuttavan aineen annosteluun ja annostelun tutkimukseen |
WO2002036077A2 (en) * | 2000-11-06 | 2002-05-10 | Andrx Pharmaceuticals, Inc. | Once a day antihistamine and decongestant formulation |
DK1372708T3 (da) | 2001-02-13 | 2008-10-20 | Us Gov Sec Army | Vaccine til transkutan immunisering mod rejsediarre |
US20030212078A1 (en) * | 2001-05-17 | 2003-11-13 | Klein Gerald L. | Topical administration of pharmacological compositions for non-systemic treatment of pruritus |
US20040265268A1 (en) * | 2001-08-18 | 2004-12-30 | Deepak Jain | Compositions and methods for skin rejuvenation and repair |
US20030099711A1 (en) * | 2001-08-29 | 2003-05-29 | David Meadows | Sustained release preparations |
US6586449B1 (en) * | 2002-05-28 | 2003-07-01 | Cambrex Charles City, Inc. | Nicotine-containing, controlled release composition and method |
US8092831B2 (en) * | 2002-11-08 | 2012-01-10 | Andrx Pharmaceuticals, Llc | Antihistamine and decongestant system |
GB0322342D0 (en) * | 2003-09-23 | 2003-10-22 | Gamble Reed | Skin patch |
WO2005053691A2 (en) | 2003-12-02 | 2005-06-16 | Fertin Pharma A/S | Nicotine delivery product and method for producing it |
US20050142097A1 (en) * | 2003-12-29 | 2005-06-30 | Deepak Thassu | Multiple active drug resin conjugate |
US20050181050A1 (en) * | 2004-01-28 | 2005-08-18 | Collegium Pharmaceutical, Inc. | Dosage forms using drug-loaded ion exchange resins |
US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
AU2005235308B2 (en) * | 2004-04-19 | 2011-12-01 | Strategic Science & Technologies, Llc | Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
US20070036843A1 (en) * | 2005-01-28 | 2007-02-15 | Collegium Pharmaceutical, Inc. | Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents |
US8318210B2 (en) | 2005-02-28 | 2012-11-27 | Neos Therapeutics, Lp | Compositions and methods of making sustained release liquid formulations |
JP2008546835A (ja) * | 2005-06-28 | 2008-12-25 | ユ セ ベ ソシエテ アノニム | 複数の活性薬物−樹脂抱合体 |
WO2008088586A2 (en) * | 2006-09-11 | 2008-07-24 | William Marsh Rice University | New phototherapeutic materials prepared through nanoparticle assembly |
WO2008151071A1 (en) * | 2007-05-30 | 2008-12-11 | Neos Therapeutics, Lp | Modifying drug release in suspensions of ionic resin systems |
US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
WO2010151241A1 (en) | 2009-06-24 | 2010-12-29 | Strategic Science & Technologies, Llc | Topical composition containing naproxen |
MX337166B (es) | 2009-06-24 | 2016-02-15 | Composicion topica que contiene ibuoprofeno. | |
CN103442723A (zh) | 2010-12-29 | 2013-12-11 | 战略科学与技术有限责任公司 | 治疗变态反应和其它适应症的系统和方法 |
CN114668851B (zh) | 2010-12-29 | 2024-11-01 | 战略科学与技术有限责任公司 | 勃起功能障碍和其它适应症的治疗 |
JP5808214B2 (ja) * | 2011-09-30 | 2015-11-10 | 株式会社トクヤマ | 貼付剤 |
FI125075B (fi) | 2012-08-13 | 2015-05-29 | Novagent Oy | Vaikuttavan aineen iontoforeettinen annostelujärjestelmä |
DE102017127433A1 (de) | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | TTS auf Basis von klebenden Weichmacher-Polymer-Matrices |
JP2019208691A (ja) * | 2018-05-31 | 2019-12-12 | 小林製薬株式会社 | 貼付剤 |
JP2019208688A (ja) * | 2018-05-31 | 2019-12-12 | 小林製薬株式会社 | 貼付剤 |
JPWO2021106212A1 (de) * | 2019-11-29 | 2021-06-03 | ||
WO2021106210A1 (ja) * | 2019-11-29 | 2021-06-03 | 小林製薬株式会社 | 貼付剤 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2501927A (en) * | 1945-05-26 | 1950-03-28 | Richard J Block | Anion exchange resin in antiirritation powder |
US2684321A (en) * | 1950-09-28 | 1954-07-20 | Rohm & Haas | Skin treating ion exchange mixture |
GB711886A (en) * | 1952-08-15 | 1954-07-14 | Rohm & Haas | Therapeutic preparations containing ion-exchange resins |
US2764518A (en) * | 1953-09-30 | 1956-09-25 | Rohm & Haas | Therapeutic mixture of carboxylic cation exchange resin and its copper salt |
US2838440A (en) * | 1953-10-29 | 1958-06-10 | Rohm & Haas | Dusting powder of carboxylic cationexchange resin and powder base |
US2919230A (en) * | 1953-10-29 | 1959-12-29 | Rohm & Haas | Hydrophilic base therapeutic compositions comprising cation-exchange resin |
US2857311A (en) * | 1954-07-06 | 1958-10-21 | Rohm & Haas | Dermatological mixture of ion-exchange resins |
US2883324A (en) * | 1955-06-16 | 1959-04-21 | Rohm & Haas | Therapeutic mixture of carboxylic cation exchange resin and its cobalt salt |
US2823163A (en) * | 1956-10-11 | 1958-02-11 | Richard K Thoms | Antivaginitis process and cation exchange resin composition |
US2951012A (en) * | 1958-03-03 | 1960-08-30 | Gisvold Ole | Poison ivy remedy |
US3567820A (en) * | 1969-04-09 | 1971-03-02 | George S Sperti | Compositions and treatment for the alleviation of diaper rash |
US3922723A (en) * | 1971-01-14 | 1975-12-02 | Karel Popper | Methods and articles for deodorizing using ion exchange manufacture |
US3922342A (en) * | 1973-05-07 | 1975-11-25 | Univ Minnesota | Poison ivy and poison oak treatment utilizing hydrophilic anion exchange material |
SU552083A1 (ru) * | 1975-06-05 | 1977-03-30 | Ордена Трудового Красного Знамени Научно-Исследовательский Институт Гигиены Труда И Профзаболеваний Амн Ссср | Защитный крем |
GB1544761A (en) * | 1976-11-26 | 1979-04-25 | Pennwalt Corp | Prolonged release pharmaceutical preparations |
SU833240A1 (ru) * | 1979-03-12 | 1981-05-30 | Московский Ордена Ленина И Орденатрудового Красного Знамени Химико- Технологический Институт Им.Д.И.Менделеева | Защитный крем дл рук |
JPS5721318A (en) * | 1980-07-14 | 1982-02-04 | Nitto Electric Ind Co Ltd | Plaster |
US4405606A (en) * | 1981-05-04 | 1983-09-20 | Evreka, Inc. | Method for arresting fulminating infection |
AU565487B2 (en) * | 1983-09-16 | 1987-09-17 | Fisons Corporation | Liquid prolonged release pharmaceutical formulations containing ionic constituents |
-
1985
- 1985-03-18 US US06/713,068 patent/US4692462A/en not_active Expired - Fee Related
-
1986
- 1986-03-15 JP JP61058015A patent/JPS61215321A/ja active Pending
- 1986-03-17 AT AT86301949T patent/ATE51342T1/de not_active IP Right Cessation
- 1986-03-17 DE DE8686301949T patent/DE3669828D1/de not_active Expired - Fee Related
- 1986-03-17 EP EP86301949A patent/EP0195643B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0195643A3 (en) | 1987-04-01 |
DE3669828D1 (de) | 1990-05-03 |
EP0195643B1 (de) | 1990-03-28 |
JPS61215321A (ja) | 1986-09-25 |
EP0195643A2 (de) | 1986-09-24 |
US4692462A (en) | 1987-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE51342T1 (de) | Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe. | |
ES2054818T3 (es) | Dispositivo mejorado para el suministro transdermal de farmacos. | |
ES2171672T3 (es) | Composiciones activadoras de penetracion en la piel mediante la utilizacion de lactilatos de acilo. | |
BR9006924A (pt) | Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos | |
EP0280737A4 (de) | Steroidenheilmittelzubereitung zur äusserlichen verwendung. | |
IE821570L (en) | Use of eucalyptol for enhancing skin permeation of¹bioaffecting agents | |
DE3778223D1 (de) | Biologisch erodierbares system mit gesteuerter freisetzung des arzneiwirkstoffes. | |
DE3579068D1 (de) | Arzneimittelenthaltende matrizen fuer einfuehrungen in zonen mit cellularen lesionen. | |
EP0164998A3 (de) | Mittel und Verfahren zur Erhöhung der transdermalen und transmembranen Penetration topischer und systemischer Wirkstoffe | |
DE68910159D1 (de) | Dosierform für Verabreichung in der Humanmedizin. | |
DE59808186D1 (de) | Transdermales therapeutisches system zur abgabe von hormonen | |
ATE173627T1 (de) | Medizinische zusammensetzung | |
CA2251966A1 (en) | Transdermally administered dextromethorphan as antitussive agent | |
ATE77230T1 (de) | Melatoninhaltige mittel sowie deren verwendungen. | |
YU49390A (sh) | Postupak za izradu transdermalnog terapijskog sistema sa stupnjevitim otpuštanjem aktivne materije | |
ES2043744T3 (es) | Sistema de suministro transdermico de procaterol. | |
IE810489L (en) | Composition for topical application | |
SE9601527D0 (sv) | Transdermally alministered acetylcysteine as mucolytic agent | |
GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
ATE190828T1 (de) | Molekulares transdermales transportsystem | |
FR2786699B1 (fr) | Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles | |
ATE28384T1 (de) | Medizinisches verfahren und zubereitung. | |
DE59908258D1 (de) | Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform | |
ES2062752T3 (es) | Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia. | |
DE69724228D1 (de) | Kombinationstherapie von topoisomerase ii toxinen und bis-dioxypiperazinderivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |